These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21492194)

  • 41. Serum C-reactive protein and iron levels following gonadectomy are not modified by perioperative administration of robenacoxib to dogs.
    Vieitez V; López-Rámis V; Barrera R; Gómez de Segura IA
    Can J Vet Res; 2022 Jan; 86(1):40-47. PubMed ID: 34975221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
    Coruzzi G; Venturi N; Spaggiari S
    Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sparing effect of robenacoxib on the minimum alveolar concentration for blunting adrenergic response (MAC-BAR) of sevoflurane in dogs.
    Tamura J; Itami T; Ishizuka T; Fukui S; Ooyama N; Miyoshi K; Sano T; Yamashita K
    J Vet Med Sci; 2014 Jan; 76(1):113-7. PubMed ID: 24004933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical pharmacology of selective COX-2 inhibitors.
    Capone ML; Tacconelli S; Sciulli MG; Patrignani P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis.
    Silber HE; Burgener C; Letellier IM; Peyrou M; Jung M; King JN; Gruet P; Giraudel JM
    Pharm Res; 2010 Dec; 27(12):2633-45. PubMed ID: 20922466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxib.
    Giraudel JM; King JN; Jeunesse EC; Lees P; Toutain PL
    J Vet Pharmacol Ther; 2009 Feb; 32(1):18-30. PubMed ID: 19161452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of oral robenacoxib and carprofen for the treatment of osteoarthritis in dogs: a randomized clinical trial.
    Edamura K; King JN; Seewald W; Sakakibara N; Okumura M
    J Vet Med Sci; 2012 Sep; 74(9):1121-31. PubMed ID: 22673598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of oral administration of robenacoxib on inhibition of paracentesis-induced blood-aqueous barrier breakdown in healthy cats.
    Sharpe EK; Meekins JM; Roush JK; Rankin AJ; KuKanich B
    Am J Vet Res; 2018 Apr; 79(4):443-449. PubMed ID: 29583043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PHARMACOKINETIC, PHARMACODYNAMIC, AND TOXICOLOGY STUDY OF ROBENACOXIB IN RAINBOW TROUT (
    Raulic J; Beaudry F; Beauchamp G; Jalenques M; Summa N; Lair S; Youcef WA; Vergneau-Grosset C
    J Zoo Wildl Med; 2021 Jun; 52(2):529-537. PubMed ID: 34130395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Superiority of the gastroduodenal safety profile of licofelone over rofecoxib, a COX-2 selective inhibitor, in dogs.
    Moreau M; Daminet S; Martel-Pelletier J; Fernandes J; Pelletier JP
    J Vet Pharmacol Ther; 2005 Feb; 28(1):81-6. PubMed ID: 15720519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical safety of robenacoxib in cats with chronic musculoskeletal disease.
    King JN; Seewald W; Forster S; Friton G; Adrian DE; Lascelles BDX
    J Vet Intern Med; 2021 Sep; 35(5):2384-2394. PubMed ID: 34196973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of meloxicam or robenacoxib administration timing on renal function and postoperative analgesia in cats undergoing ovariohysterectomy: A randomized, blinded, controlled clinical trial.
    Krekis A; King JN; D'Arcy-Howard D; Stapleton N; Elliott J; Pelligand L
    J Vet Pharmacol Ther; 2024 May; 47(3):175-186. PubMed ID: 38235901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of the route of excretion of robenacoxib (Onsior™) in cats and dogs: A pilot study.
    King JN; Jung M
    J Vet Pharmacol Ther; 2021 May; 44(3):411-416. PubMed ID: 33881783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
    Giovanni G; Giovanni P
    J Nephrol; 2002; 15(5):480-8. PubMed ID: 12455713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
    Emkey R; Rosenthal N; Wu SC; Jordan D; Kamin M;
    J Rheumatol; 2004 Jan; 31(1):150-6. PubMed ID: 14705234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations.
    Goltsov A; Maryashkin A; Swat M; Kosinsky Y; Humphery-Smith I; Demin O; Goryanin I; Lebedeva G
    Eur J Pharm Sci; 2009 Jan; 36(1):122-36. PubMed ID: 19028575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.